AOSSM Specialty Day 2023 with ISAKOS with CME-3. AOSSM-ISAKOS - Session III

Video Transcription

Video Summary

The video is a presentation by Chuck Hsu from the Stedman Clinic in Vail, Colorado. The presentation focuses on the use of Losartan, an FDA-approved medication for hypertension, as a potential treatment to reduce fibrosis and scar formation in patients undergoing primary hip arthroscopy. The speaker discusses the rise in the number of revision cases following hip arthroscopy and the common indications for revision surgery. They explain the role of fibrosis and scar tissue formation in complications and pain after the surgery. Basic science studies have shown that Losartan can inhibit fibrosis without severe side effects. The speaker presents a retrospective review of 917 cases and finds that patients treated with Losartan had lower rates of reoperation and revision hip arthroscopy compared to those not treated with Losartan. The study suggests that incorporating Losartan into postoperative protocols can reduce the need for revision surgery and improve patient outcomes.

Keywords

Chuck Hsu

Stedman Clinic

Losartan

primary hip arthroscopy

fibrosis and scar formation